search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
LIMS & Lab Automation


Unique LabWare 8 Platform Combines LIMS, ELN and LES Method Execution Capabilities


LabWare is a Key Partner in Helping Laboratories Respond to COVID-19


LabWare has been actively working with public and private sector organisations worldwide to apply our considerable know-how and advanced technology to implement COVID-19 testing capability and other workfl ow and operational effi ciency enhancements. This is helping to increase laboratory testing capacity to meet unprecedented public health testing demands.


LabWare’s efforts include assisting in the efforts to expand the UK’s COVID-19 testing operations: supporting both UK and global Vaccine manufacturing operations; providing laboratory management software for new COVID-19 laboratories in other regions of the world; assisting US public health customers to implement new COVID-19 tests and communications protocols for reporting to the CDC; adding/expanding COVID-19 testing capabilities throughout their public health customer base in sub-Saharan Africa, and assisting Canadian public health customers with performance improvements to handle the surge of COVID-19 tests.


LabWare are developing solutions, including the Portable Disease Surveillance Lab (PDSL) that leverage LabWare’s Mobile technology to streamline the COVID-19 patient registration and sample collection process as part of fi eld-based specimen collection and COVID-19 testing operations. These solutions are being deployed at the company’s US State Public Health customers


LabWare 8 is the foundation for LabWare’s unique Enterprise Laboratory Platform which brings together the capabilities of a Laboratory Information Management System (LIMS) and an Electronic Laboratory Notebook (ELN) in a single comprehensive solution. LabWare 8 is the most adaptable and functionally complete LIMS system and offers a proven solution for any size laboratory.


The Enterprise Laboratory Platform is scalable to suit every size organisation. Customers range from single site, single user implementations to global organisations with more than 100 sites and 1000’s of users. LabWare 8 offers new levels of system performance, features for comprehensive compliance with Regulatory Data Integrity mandates, and a wide range of new functions that improve both the end user experience and system administrative tasks.


The areas of emphasis for LabWare 8 include: end user functionality and ease of use • technology and security • regulatory compliance (Regulatory Data Integrity) • system performance • administration enhancements.


More information online: ilmt.co/PL/5qlg 54390pr@reply-direct.com More information online: ilmt.co/PL/JOpO 54391pr@reply-direct.com


MOBILE app Allows Easy Connectivity to LabWare LIMS


LabWare MOBILE allows users to easily connect to their LabWare systems, see their data and perform customer-defi ned tasks. End users and management can easily get the data they need while trusting the security features applied throughout the LabWare platform. Whether optimising an existing process or creating an entirely new workfl ow, the LabWare MOBILE app fully complements LabWare LIMS and can be used to perform typical laboratory functions such as:


Sample Login • Sample Receipt • Test Assignment • Result Entry • Data Reviewing • Reporting • Instrument Management • and More.


Native features include: creating and uploading fi les and photos • camera, including barcode scanning and QR codes • GPS/Location and interface to Mapping App • PDF viewing • date spinners, keypad, keyboard, autocorrect, dictation, etc.


More information online: ilmt.co/PL/dpkX 54392pr@reply-direct.com


Laboratory Automation Technology for the Future


LabWare leverages state of the art technology built on a platform that enables seamless modular-based deployment of functionality to customers. The company’s unique industry approach ensures the longevity and upgradability of all our customers systems. This means upgrades are driven by the customers desire to increase functionality, and not driven by changes in the technology itself, ensuring value and avoiding non-value added system upgrades.


LabWare’s unique approach to Laboratory Automation has ensured its position as the world’s #1 LIMS by enabling them to be the most functional, confi gurable, easily integrated solution, delivering the most value to customers with the robust and future focused solution that they need. More information online: ilmt.co/PL/yALR


54393pr@reply-direct.com


Data Integrity for Challenging Regulatory Environments


LabWare continues to deploy solutions that meet the challenging regulatory requirements for all the industries they support. The company are constantly evolving to ensure they meet the future needs in regulatory environments that continue to become more data- and system-centric.


In association with a customer’s procedures and quality systems, LabWare offers a confi gurable solution that can provide a compliant and validated environment for the functions used. With comprehensive auditing, review functionality, and system controls, these implementations have been proven to meet the demands of agencies such as the FDA, MHRA, and WHO in GMP and GLP laboratories.


More information online: ilmt.co/PL/0alD 54394pr@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40